CinCor Pharma, Inc.
DelistedCIK 1868734fmd_0Z7J7F7FFQZRN6CY5SZ6D1TFQ8Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2022, 8 periods
Latest annual · FY2021
Millions- Operating income
- (43)
- Net income
- (50)
Latest quarter · Q3 FY2022
Millions- Operating income
- (22)
- Net income
- (21)
- Free cash flow
- (15)
CinCor Pharma, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Operating income | -$42.5 million | -$21.1 million | 10-K 2022-03-22 · proof | |
| Net income | -$50.4 million | -$22.3 million | 10-K 2022-03-22 · proof | |
| Cash from operating activities | -$30.8 million | -$17.4 million | 10-K 2022-03-22 · proof | |
| Total assets | $141.1 million | $26.8 million | +426.5% | 10-K 2022-03-22 · proof |
| Total liabilities | $204.8 million | $54.1 million | +278.8% | 10-K 2022-03-22 · proof |
| Cash and cash equivalents | $136.6 million | $26.1 million | +423.8% | 10-K 2022-03-22 · proof |
- What was CinCor Pharma, Inc.'s operating income in fiscal 2021?
- CinCor Pharma, Inc. reported operating income of -$42.5 million for fiscal 2021 (the year ended Dec 31, 2021), against -$21.1 million the year before. Source: the 10-K filed with the SEC on Mar 22, 2022. SEC
- What was CinCor Pharma, Inc.'s net income in fiscal 2021?
- CinCor Pharma, Inc. reported net income of -$50.4 million for fiscal 2021 (the year ended Dec 31, 2021), against -$22.3 million the year before. Source: the 10-K filed with the SEC on Mar 22, 2022. SEC
- What was CinCor Pharma, Inc.'s cash from operating activities in fiscal 2021?
- CinCor Pharma, Inc. reported cash from operating activities of -$30.8 million for fiscal 2021 (the year ended Dec 31, 2021), against -$17.4 million the year before. Source: the 10-K filed with the SEC on Mar 22, 2022. SEC
- What are CinCor Pharma, Inc.'s total assets?
- As of Dec 31, 2021, CinCor Pharma, Inc. reported total assets of $141.1 million, against $26.8 million a year earlier (+426.5%). Source: the 10-K filed with the SEC on Mar 22, 2022. SEC
- What are CinCor Pharma, Inc.'s total liabilities?
- As of Dec 31, 2021, CinCor Pharma, Inc. reported total liabilities of $204.8 million, against $54.1 million a year earlier (+278.8%). Source: the 10-K filed with the SEC on Mar 22, 2022. SEC
- What are CinCor Pharma, Inc.'s cash and cash equivalents?
- As of Dec 31, 2021, CinCor Pharma, Inc. reported cash and cash equivalents of $136.6 million, against $26.1 million a year earlier (+423.8%). Source: the 10-K filed with the SEC on Mar 22, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1868734&period_type=annual&limit=5"Information only, not investment advice.